Skip to main content

Advertisement

Figure 1 | BMC Cancer

Figure 1

From: In vitro evaluation of novel N-acetylalaninate prodrugs that selectively induce apoptosis in prostate cancer cells

Figure 1

Moieties of the N-acetylalaninate prodrug. The N-acetylalaninate prodrugs are hybrids of two esters. We previously demonstrated that the N-acetylalaninate moiety (A) is specifically hydrolyzed by OPH in prostate cell lines [24]. The GSH depleting ability of the quinone methide (QM) generating moiety (B) is well documented. Combining these two moieties creates an ester substrate that is specifically activated by OPH to generate a QM, which depletes GSH (see FigureĀ 2).

Back to article page